ArticleScientific reports2025
Machine learning based analysis of leucocyte cell population data by Sysmex XN series hematology analyzer for the diagnosis of bacteremia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Assessment of intracellular complexity of monocyte through cell population data (CPD) can lead to early recognition of bloodstream infections.Archives of microbiology · 2026Observational
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
In clinical practice, early recognition of bacteremia leads to prognostic improvement. Recently, cell population data (CPD) from the Sysmex XN-series hematology analyzer has attracted attention as a new method for the early diagnosis of bacteremia, but its usefulness in clinical practice remains unclear. We focused on the fluorescent light distribution of the neutrophil area (NE-WY) and used machine learning to determine whether predictions could be improved. Among adult patients with clinically suspected bacteremia at our hospital, 533 who did not meet the exclusion criteria were enrolled. Propensity score matching was performed for bacteremia (n = 106) and non-bacteremia (n = 427) cases. NE-WY showed the largest difference between the two groups (AUC, 0.768; sensitivity, 73.6%; specificity, 67.9%; cutoff value, 686.5(no unit)). In machine learning, the first branch of the decision tree was NE-WY, and the cutoff value was set at 689.5(no unit). Support vector machines were used to examine multiple variables, but there were no significant differences relative to NE-WY alone. This is the first report to demonstrate that NE-WY is useful for detecting bacteremia by analyzing CPD using machine learning. The combination of CPD and machine learning is expected to produce new results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.